Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ashcroft

Showing results (661-670 of 759) with videos related to

Pageof 76
Sort By:
Diabetes|May 20, 1999
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in FinlandT Otonkoski, C Ammälä, H Huopio, et al.
The British Journal of Dermatology|September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)I Y K Iskandar, D M Ashcroft, R B Warren, et al.
BMJ Open|December 8, 2025
Risk prediction in people with acute myocardial infarction in England: a cohort study using data from 1521 general practicesEvangelos Kontopantelis, Salwa S Zghebi, Corneliu T Arsene, et al.
Cell Metabolism|November 13, 2018
Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP ProductionJakob G Knudsen, Alexander Hamilton, Reshma Ramracheya, et al.
Clinical Case Reports|October 29, 2015
The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutationSusan M O'Connell, Peter Proks, Holger Kramer, et al.
Diabetes|August 2, 2013
A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1Kenju Shimomura, Maija Tusa, Michaela Iberl, et al.
Nature Communications|November 14, 2022
Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cellsElizabeth Haythorne, Matthew Lloyd, John Walsby-Tickle, et al.
BMJ Quality & Safety|May 7, 2026
The incidence of avoidable healthcare-associated harm in prisons in England: a retrospective case note reviewIsobel Joy McFadzean, Saied Ibrahim, Verity Wainwright, et al.
The Lancet Regional Health. Europe|September 6, 2023
Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in EnglandVicky P Taxiarchi, Morwenna Senior, Darren M Ashcroft, et al.
Diabetes Care|January 31, 2022
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 DiabetesAlison K Wright, Matthew J Carr, Evangelos Kontopantelis, et al.
Pageof 76

Showing results (661-670 of 759) with videos related to

Sort By:
Pageof 76
Diabetes|May 20, 1999
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in FinlandT Otonkoski, C Ammälä, H Huopio, et al.
The British Journal of Dermatology|September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)I Y K Iskandar, D M Ashcroft, R B Warren, et al.
BMJ Open|December 8, 2025
Risk prediction in people with acute myocardial infarction in England: a cohort study using data from 1521 general practicesEvangelos Kontopantelis, Salwa S Zghebi, Corneliu T Arsene, et al.
Cell Metabolism|November 13, 2018
Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP ProductionJakob G Knudsen, Alexander Hamilton, Reshma Ramracheya, et al.
Clinical Case Reports|October 29, 2015
The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutationSusan M O'Connell, Peter Proks, Holger Kramer, et al.
Diabetes|August 2, 2013
A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1Kenju Shimomura, Maija Tusa, Michaela Iberl, et al.
Nature Communications|November 14, 2022
Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cellsElizabeth Haythorne, Matthew Lloyd, John Walsby-Tickle, et al.
BMJ Quality & Safety|May 7, 2026
The incidence of avoidable healthcare-associated harm in prisons in England: a retrospective case note reviewIsobel Joy McFadzean, Saied Ibrahim, Verity Wainwright, et al.
The Lancet Regional Health. Europe|September 6, 2023
Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in EnglandVicky P Taxiarchi, Morwenna Senior, Darren M Ashcroft, et al.
Diabetes Care|January 31, 2022
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 DiabetesAlison K Wright, Matthew J Carr, Evangelos Kontopantelis, et al.
Pageof 76